• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Carl Zeiss Meditec, Calhoun partner on light-adjustable lens

Article

Pasadena, CA-A research and supply partnership will combine Carl Zeiss Meditec AG's digital light delivery system with Calhoun Vision Inc.'s light-adjustable lens (LAL).

Pasadena, CA-A research and supply partnership will combine Carl Zeiss Meditec AG ' s digital light delivery system with Calhoun Vision Inc.'s light - adjustable lens ( LAL ).

The LAL uses specific patterns of light to give a patient optimal vision after cataract surgery. In early clinical studies, the lens has been customized noninvasively while in the patient's eye.

"We believe this technology will set a new paradigm for quality of vision for both cataract surgery and refractive surgery," said Calhoun President Cary Reich, PhD. "We are delighted to be working with the premier company in the field of ophthalmic optical instrumentation to develop our platform technology further.OT

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.